Despite rapid advances in quantum algorithms and hardware, translating these developments into concrete, verifiable real-world applications remains a major challenge. Here, we present Quantum AI-Scientist, a retrieval-augmented, multi-agent framework for discovering potential applications of quantum computing in biomedicine. Unlike conventional AI-scientist systems designed to solve predefined tasks, Quantum AI-Scientist identifies computational problems within a biomedical research domain that may benefit from quantum primitives. Four coordinated agents retrieve and analyze literature data to characterize the capabilities of quantum primitives, identify structurally compatible biomedical problems, translate candidate applications into falsifiable evaluation plans, and synthesize the resulting evidence to rank candidates and recommend further development strategies. The framework maintains a traceable evidence chain of literature-derived evidence, computational formulations, experimental results, and final recommendations. It also explicitly distinguishes structural compatibility from practical executability, empirical improvement, and quantum advantage. Across eight biomedical benchmarks, the staged workflow increased the macro-F1 score for formulation recovery from 82.6% to 88.1% compared with an equal-evidence, single-call baseline, while reducing token consumption at the cost of increased API latency. Case studies involving spatial probe selection and cell lineage inference demonstrate how proposed applications can be translated into executable evaluations of technical feasibility, preliminary empirical improvement, and quantum advantage. Collectively, these results establish a systematic and auditable framework for proposing, testing, and prioritizing biomedical applications of quantum computing.
Despite rapid advances in quantum algorithms and hardware, translating these developments into concrete, verifiable real-world applications remains a major challenge. Here, we present Quantum AI-Scientist, a retrieval-augmented, multi-agent framework for discovering potential applications of quantum computing in biomedicine. Unlike conventional AI-scientist systems designed to solve predefined tasks, Quantum AI-Scientist identifies computational problems within a biomedical research domain that may benefit from quantum primitives. Four coordinated agents retrieve and analyze literature data to characterize the capabilities of quantum primitives, identify structurally compatible biomedical problems, translate candidate applications into falsifiable evaluation plans, and synthesize the resulting evidence to rank candidates and recommend further development strategies. The framework maintains a traceable evidence chain of literature-derived evidence, computational formulations, experimental results, and final recommendations. It also explicitly distinguishes structural compatibility from practical executability, empirical improvement, and quantum advantage. Across eight biomedical benchmarks, the staged workflow increased the macro-F1 score for formulation recovery from 82.6% to 88.1% compared with an equal-evidence, single-call baseline, while reducing token consumption at the cost of increased API latency. Case studies involving spatial probe selection and cell lineage inference demonstrate how proposed applications can be translated into executable evaluations of technical feasibility, preliminary empirical improvement, and quantum advantage. Collectively, these results establish a systematic and auditable framework for proposing, testing, and prioritizing biomedical applications of quantum computing.
The integration of quantum computing and artificial intelligence (AI) constitutes a bidirectional synergy that is reshaping both disciplines. This review investigates the reciprocal relationship in which AI addresses foundational challenges in quantum computing, while quantum computing offers the potential to advance machine learning beyond classical constraints. Recent advancements exemplify this interaction: Google DeepMind’s AlphaQubit neural network decoder has achieved state-of-the-art quantum error correction, improving performance by 6% over tensor networks and 30% over correlated matching methods. Additionally, quantum neural networks have demonstrated exponential improvements in sample complexity for specific learning tasks. This review systematically examines the current landscape of quantum-AI integration across three primary dimensions. First, it addresses AI-enhanced quantum systems, such as transformer-based error correction, reinforcement learning for circuit optimization, and AI-driven hardware calibration. Second, it explores quantum-accelerated machine learning algorithms, including variational quantum neural networks, quantum generative adversarial networks, and quantum reinforcement learning. Third, it evaluates industry deployments in sectors such as life sciences, financial services, climate modeling, and pharmaceutical development. Notable examples include IonQ’s quantum chemistry simulations, which achieved 40% efficiency improvements in carbon capture material design; St. Jude’s identification of KRAS protein inhibitors using quantum machine learning with experimental validation; and JP Morgan Chase’s implementation of quantum portfolio optimization. The analysis indicates that the field has advanced from preliminary demonstrations to production-grade applications, especially in drug discovery and molecular simulation, where quantum computing offers measurable benefits. Nevertheless, several challenges remain, including barren plateaus in variational algorithms, scalability constraints in current noisy intermediate-scale quantum (NISQ) devices, requirements for real-time decoding speed, and the necessity for fault-tolerant quantum computing (FTQC) systems. IBM’s 2029 roadmap, which targets 200 logical qubits capable of executing 100 million gates, together with progress in high-rate quantum low-density parity-check codes, outlines a trajectory toward practical fault tolerance. This review makes two principal research contributions: Comprehensive Evaluation Framework for Quantum Advantage Assessment: We establish the first systematic, integrated methodology for determining quantum computing feasibility that combines problem characterization, resource estimation, quantum advantage assessment, and quantum algorithm paradigm selection. This framework consolidates criteria scattered across academic literature and industry practice into a unified decision-making tool applicable across chemistry, optimization, machine learning, and simulation domains. The framework addresses a critical industry need: enabling non-expert practitioners (chemists, financial analysts, materials scientists) to objectively assess quantum computing suitability without requiring deep quantum expertise. Novel Quantum Resource Optimization Algorithms: We present three concrete algorithmic contributions advancing quantum-AI integration: • Data Encoding Efficiency Algorithm that automatically selects optimal qubit encoding strategies (amplitude vs. angle encoding) minimizing total quantum resource consumption • Error Budget Optimization Algorithm that iteratively determines optimal quantum error correction code distance balancing logical error rate targets against physical qubit overhead • Real-time Hardware Specification Aggregation from multiple quantum cloud platforms (IBM Quantum, Amazon Braket, Google, IonQ) enabling dynamic feasibility assessment as hardware capabilities evolve Combined, these contributions establish quantum computing advantage assessment as a rigorous, data-driven discipline rather than ad-hoc expert judgment. The framework enables strategic quantum computing investment decisions, accelerates problem identification for early quantum utility, and provides a reference methodology for standardizing quantum advantage evaluation across academia and industry. This review synthesizes insights from recent academic literature, industry implementations, and expert perspectives to deliver a comprehensive assessment of quantum-AI synergies grounded in this evaluation framework. The mathematical foundations, ranging from quantum Fourier transforms to Gaussian processes, are examined. Best practices for researchers and practitioners are also outlined. The findings suggest that, although universal quantum advantage has not yet been realized, domain-specific quantum-AI applications in chemistry, optimization, and sensing are achieving practical utility in 2024-2025. This development marks a significant transition from theoretical potential to commercial realization, informed by rigorous evaluation methodologies.
Classical biomedical simulation such that molecular dynamics, protein folding and in silico screening face significant limitations including scaling exponentially, crude approximations, and long simulation times. Since biological simulations are fundamentally quantum; classical models rely on crude approximations. Instead, quantum simulation brings to qubits a mapping of the systems of molecules, such that it is possible to compute their energetics and conformations with fidelity to physics. A hybrid digital pipeline with quantum techniques consists of uniting artificial intelligence (AI) with massive biomedical data warehousing, quantum-enhanced solvers compare interactions at the atomic scale, and results are reinvested in prioritization before anything is done in a wet lab. This review synthesizes the existing literature and summarizes the existing knowledge in the field of peer-reviewed articles as algorithms (e.g., VQE, annealing, QML), biomedical application (drug discovery, oncology, genomics, diagnostics), and results of the process (accuracy, runtime, cost, and reproducibility). The findings demonstrate an evident shift to hybrid quantum classical architectures that are more fidelity to modeling, less assays early stage due to virtual experimentation, and compress the research-to-treatment timeline claiming that quantum-AI is an emergent experimental basis of biomedicine.
Precision medicine aims to tailor healthcare by integrating individual genetic, epigenetic, transcriptomic, proteomic, and clinical data, collectively referred to as multi-omic data. However, the scale and complexity of such multi-omics datasets challenge classical computing approaches. Quantum computing, which leverages superposition and entanglement (quantum-level correlations between particles), offers a fundamentally new paradigm for accelerating molecular simulations, biomarker discovery, and high-dimensional data analysis. This review explores the convergence of quantum computing and it's potential to provide unmet needs in precision biomedicine research, with emphasis on applications in diagnostic modeling, multi-omic data integration and drug discovery. We highlight early proof-of-concept studies demonstrating the use of quantum machine learning for disease prediction, quantum algorithms for protein folding, and quantum generative models for novel drug design. Hybrid quantum-classical workflows are also already enabling gene network inference and prioritization of variants of uncertain significance, the latter of which is a major focus of multi-omic research worldwide. Emerging directions include digital twin simulations and real-time clinical decision support powered by quantum models. Looking ahead, the long-term vision for quantum computing in biomedicine involves in silico modeling of entire biological systems to simulate cellular responses to perturbations like drug treatments, enabling clinicians to test therapies in virtual patients before real-world application. Despite these advances, practical implementation remains limited by hardware constraints, qubit decoherence, algorithm scalability, and regulatory barriers. Nonetheless, as quantum hardware evolves and AI-aligned quantum algorithms mature, their integration holds transformative potential. Quantum computing may eventually shorten diagnostic timelines, improve therapeutic precision, and make biomedical innovation more globally accessible. We outline a roadmap for translating these technologies into next-generation precision medicine.
Objective: To synthesize the state of the art on how quantum computing (QC) and artificial intelligence (AI) intersect, including algorithmic foundations, software/hardware stacks, empirical evidence of advantage, applications, and open challenges. Methods: We executed a structured search (2019 – 20th August 2025) across major journals (Nature portfolio, APS/PR, Elsevier), arXiv, and official framework documentation (Qiskit, Cirq/TFQ, PennyLane; AWS Braket; NVIDIA CUDA-Q). We included peer‑reviewed studies, comprehensive surveys, and official docs; we excluded opinion pieces and non-reproducible claims. Results: The field converges on hybrid quantum‑classical workflows with two dominant AI families: (i) quantum kernel methods and (ii) variational circuits/QNNs. Trainability remains a core challenge (barren plateaus and noise), with mitigation strategies advancing (local costs, layerwise training, engineered dissipation, learned decoders). Frameworks and cloud orchestrators now support end‑to‑end hybrid training. Empirical “utility” demonstrations in physics‑inspired tasks exist, while domain‑level advantage in mainstream ML is unproven and data‑dependent. Conclusions: QC‑AI integration is maturing into reproducible hybrid stacks. Near‑term value lies in quantum kernels with tailored feature maps, physics‑regularized QNNs, simulator‑accelerated pipelines, and AI‑for‑QC (calibration/decoding). Broad ML advantage awaits lower‑noise hardware and quantum‑friendly data embeddings.
Quantum computing (QC) is emerging as a transformative computational paradigm with the potential to reshape several data and compute-intensive domains, including healthcare. This paper presents a structured survey of Thirty-two representative studies published between 2016 and 2026 on quantum computing applications in healthcare, covering drug discovery, genomics, medical imaging, diagnostics, personalized medicine, and healthcare operations. We classify seven families of quantum and hybrid quantum-classical algorithms relevant to biomedical problems and present comparative analyses of classical versus quantum approaches through four illustrative figures and three comparison tables. The survey further synthesizes the principal advantages reported for quantum-enabled healthcare solutions against the hardware, software, economic, workforce, and regulatory barriers that currently limit real-world deployment. Consistent with recent large-scale systematic reviews, our analysis finds that most reported healthcare-oriented quantum results remain small-scale proof-of-concept demonstrations on simulators or NISQ hardware, with limited evidence to date of consistent quantum advantage over classical baselines. The paper concludes with a set of near-term, hybrid-first research directions intended to help researchers and practitioners prioritize feasible next steps toward clinically viable quantum-assisted healthcare systems.
Quantum computing is increasingly explored for software engineering (SE) optimization, but translating natural-language (NL) task-level requirements into executable quantum applications still demands substantial quantum and programming expertise. We present QPipe, a large language model (LLM)-based multi-agent architecture that autonomously turns NL requirements into traceable quantum-application workflows through specialized agents for requirement parsing, formulation, code generation, review, execution, and verification. We evaluate QPipe on 20 NL requirements, each associated with a real-world benchmark and a test-optimization problem. QPipe successfully completes the key stages of quantum-application generation across requirements, achieving average rates of 100% for code compilation and 96.7% for application execution and final-result combination, with average generation costs of 260.1 seconds and 1.89M tokens per requirement. Among the generated quantum applications that execute successfully, the returned solutions outperform the offline genetic algorithm baseline in most cases. Ablation results further show that QPipe's advantage depends on retaining code-generation skills, task knowledge, review feedback, and multi-agent decomposition. These results indicate that agentic coordination can support generation of executable quantum applications for tackling test optimization problems from real-world benchmarks.